Skip To Main Content
Khalid Parvez Babar on Muck Rack

Khalid Parvez Babar

As seen in: Nature, The Professional Medical Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Khalid Parvez

Contact Khalid Parvez, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource

|
By Christopher Koch, Shruthi Bandyadka, Brian R Doyon, Daniel Denning, Muhammad Jahanzaib, Muhammad Mian, Muhammad Bilal Liaqat, Lubna Kamani, Nazish Butt, Anjum Jalal, Riffat Sultana, Shahid Abbas, Musfireh Siddiqeh, Muhammad Bilal, Asadullah Khan, Khalid Parvez Babar, Javed Iqbal, Umar Usman, Muhammad Bajwa, Ali Hyder, Muhammad Sadik Memon, Nauman Hashmani, Ambreen Muddassir, Mateen Akram, MUHAMMAD HUSSAIN, Saima Mohsin Verified, Tariq Mehmood, Shahid Mukhtar, Adil Mahmood, Sheraz Khan, Muhammad Khan, Noor ul Hadi, Roshina Anjum, Rehan Abdullah, Muhammad Usman Musharraf, Muhammad Bashir, Muhammad Shoaib Ali, Irfan Majeed, Shahzad Ali Khan, Ikuyo Kou, Wataru Morii, Katherine Smith, Kousik Kundu, Stewart MacArthur, Sebastian Wasilewski, Slavé Petrovski, Juan L Rodriguez-Flores, Moeen Riaz, Manav Kapoor, Joshua Backman, Alan R. Shuldiner, James E. Bradner, Asif Rasheed, John E. Dominy, Allan M Gurtan, Danish Saleheen, Wafa Gul, Aneeqa Bano, Marium Dahar, Namra Saqib, Aflak Rasheed, Faizan Aslam, Mohsin Iqbal Haroon, Samreen Bugti, Abdul Lateef Rodeni, Tahir Rasool, Muhammad Noor Wazir, Rahmat Ghaffar, Sanaullah Jan, Chihiro Hata, Makoto Asaumi, Kieren Lythgow, Igor Splawski
| Nature Verified
Abstract Naturally occurring loss-of-function variants in human genes enable drug target discovery because they mimic pharmacological inhibition of proteins. However, the study of these genetic variants is constrained by their rarity. Sequencing of diverse populations, particularly those enriched in familial relatedness, has been postulated to promote discovery of rare genetic variants1,2,3.
Open in Who Shared Issue with article?

Tofacitinib plus methotrexate versus tofacitinib monotherapy in rheumatoid arthritis: A comprehensive evidence synthesis and critical analysis.

|
By Zainab Asim, Mahpara Munir, Khalid Parvez Babar
| The Professional Medical Journal Verified
Abstract Objective: To compare the benefits of Tofacitinib with Methotrexate vs Tofacitinib alone with respect to efficacy and safety over a period of 6 months. Study Design: Randomized Controlled Trial. Setting: Outpatient Department of Rheumatology, Madinah Teaching Hospital, Faisalabad. Period: 01st August,2025 to 31st Jan,2026. Methods: Consisted of 60 people enrolled as per the inclusion criteria (ACR/EULAR 2010 Criteria), after getting approval from the ethics review committee.
Open in Who Shared Issue with article?
See all 2 licensed articles (3 Total)